Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.57665076 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.36397062 |
3 | sodium ion export (GO:0071436) | 5.30500959 |
4 | vocalization behavior (GO:0071625) | 5.23480607 |
5 | neuron cell-cell adhesion (GO:0007158) | 5.04293911 |
6 | short-term memory (GO:0007614) | 5.01664588 |
7 | glutamate secretion (GO:0014047) | 4.97888084 |
8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.85000388 |
9 | neuronal action potential propagation (GO:0019227) | 4.84219258 |
10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.70178626 |
11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.62132738 |
12 | locomotory exploration behavior (GO:0035641) | 4.60022208 |
13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.58268202 |
14 | synaptic vesicle maturation (GO:0016188) | 4.51999967 |
15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.47302153 |
16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.42972039 |
17 | cellular sodium ion homeostasis (GO:0006883) | 4.41047246 |
18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.36860839 |
19 | protein localization to synapse (GO:0035418) | 4.36832855 |
20 | cerebellar Purkinje cell layer development (GO:0021680) | 4.36397251 |
21 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.34448943 |
22 | neuron-neuron synaptic transmission (GO:0007270) | 4.25546523 |
23 | neurotransmitter secretion (GO:0007269) | 4.20863974 |
24 | glutamate receptor signaling pathway (GO:0007215) | 4.12780464 |
25 | regulation of synaptic vesicle transport (GO:1902803) | 4.11909730 |
26 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.06472421 |
27 | C4-dicarboxylate transport (GO:0015740) | 4.05811439 |
28 | synaptic transmission, glutamatergic (GO:0035249) | 4.04495269 |
29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.01871514 |
30 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.01679502 |
31 | cell differentiation in hindbrain (GO:0021533) | 4.00851686 |
32 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.98870860 |
33 | neurofilament cytoskeleton organization (GO:0060052) | 3.88869293 |
34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.88614010 |
35 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.86441217 |
36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.78944407 |
37 | exploration behavior (GO:0035640) | 3.78721890 |
38 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.77854548 |
39 | cell communication by electrical coupling (GO:0010644) | 3.74933297 |
40 | proline transport (GO:0015824) | 3.69901462 |
41 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.68157443 |
42 | gamma-aminobutyric acid transport (GO:0015812) | 3.65908805 |
43 | presynaptic membrane assembly (GO:0097105) | 3.64167905 |
44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.62622106 |
45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61290420 |
46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.59783854 |
47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.59350056 |
48 | acidic amino acid transport (GO:0015800) | 3.58752858 |
49 | neurotransmitter transport (GO:0006836) | 3.57847041 |
50 | potassium ion homeostasis (GO:0055075) | 3.57784508 |
51 | membrane depolarization during action potential (GO:0086010) | 3.53955293 |
52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.52257434 |
53 | serotonin metabolic process (GO:0042428) | 3.51132612 |
54 | synaptic vesicle endocytosis (GO:0048488) | 3.50451895 |
55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.49189842 |
56 | cellular potassium ion homeostasis (GO:0030007) | 3.48715356 |
57 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48440066 |
58 | positive regulation of synapse maturation (GO:0090129) | 3.47963250 |
59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46732095 |
60 | long-term synaptic potentiation (GO:0060291) | 3.44326268 |
61 | response to histamine (GO:0034776) | 3.43273138 |
62 | neuronal ion channel clustering (GO:0045161) | 3.43088234 |
63 | presynaptic membrane organization (GO:0097090) | 3.41347231 |
64 | adult walking behavior (GO:0007628) | 3.40982731 |
65 | mating behavior (GO:0007617) | 3.38316338 |
66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.37903154 |
67 | neuron recognition (GO:0008038) | 3.37786630 |
68 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.37776078 |
69 | regulation of neurotransmitter secretion (GO:0046928) | 3.36939972 |
70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.35798157 |
71 | positive regulation of dendritic spine development (GO:0060999) | 3.35501053 |
72 | regulation of neurotransmitter levels (GO:0001505) | 3.32581733 |
73 | transmission of nerve impulse (GO:0019226) | 3.30477998 |
74 | membrane depolarization (GO:0051899) | 3.29986461 |
75 | long-term memory (GO:0007616) | 3.29231317 |
76 | detection of calcium ion (GO:0005513) | 3.27316904 |
77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.26456592 |
78 | L-amino acid import (GO:0043092) | 3.26126586 |
79 | L-glutamate transport (GO:0015813) | 3.25853896 |
80 | potassium ion import (GO:0010107) | 3.25776241 |
81 | negative regulation of dendrite development (GO:2000171) | 3.25473576 |
82 | neuromuscular synaptic transmission (GO:0007274) | 3.23737623 |
83 | regulation of vesicle fusion (GO:0031338) | 3.22630414 |
84 | regulation of synaptic plasticity (GO:0048167) | 3.22215943 |
85 | regulation of glutamate secretion (GO:0014048) | 3.21735165 |
86 | innervation (GO:0060384) | 3.18525028 |
87 | cerebellar granule cell differentiation (GO:0021707) | 3.18098410 |
88 | synaptic transmission, dopaminergic (GO:0001963) | 3.18013971 |
89 | regulation of synapse structural plasticity (GO:0051823) | 3.14993713 |
90 | postsynaptic membrane organization (GO:0001941) | 3.14878817 |
91 | primary amino compound metabolic process (GO:1901160) | 3.13028450 |
92 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.13009196 |
93 | membrane hyperpolarization (GO:0060081) | 3.12913128 |
94 | behavioral response to cocaine (GO:0048148) | 3.12202149 |
95 | cell communication involved in cardiac conduction (GO:0086065) | 3.10988146 |
96 | positive regulation of membrane potential (GO:0045838) | 3.10856963 |
97 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.10751742 |
98 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.10751742 |
99 | neuronal action potential (GO:0019228) | 3.10211692 |
100 | synaptic transmission (GO:0007268) | 3.10090403 |
101 | regulation of neurotransmitter transport (GO:0051588) | 3.09440490 |
102 | amino acid import (GO:0043090) | 3.07799728 |
103 | synapse assembly (GO:0007416) | 3.06485995 |
104 | auditory behavior (GO:0031223) | 3.05743307 |
105 | chemosensory behavior (GO:0007635) | 3.04283075 |
106 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.03979347 |
107 | regulation of protein kinase A signaling (GO:0010738) | 2.98447071 |
108 | prepulse inhibition (GO:0060134) | 2.98301883 |
109 | calcium ion-dependent exocytosis (GO:0017156) | 2.97712174 |
110 | activation of protein kinase A activity (GO:0034199) | 2.97575463 |
111 | neuromuscular process controlling posture (GO:0050884) | 2.97522681 |
112 | establishment of synaptic vesicle localization (GO:0097480) | 2.95122112 |
113 | synaptic vesicle transport (GO:0048489) | 2.95122112 |
114 | layer formation in cerebral cortex (GO:0021819) | 2.94309827 |
115 | transferrin transport (GO:0033572) | 2.93071609 |
116 | positive regulation of synapse assembly (GO:0051965) | 2.92606032 |
117 | intraspecies interaction between organisms (GO:0051703) | 2.91665914 |
118 | social behavior (GO:0035176) | 2.91665914 |
119 | axonal fasciculation (GO:0007413) | 2.91530367 |
120 | vesicle transport along microtubule (GO:0047496) | 2.91218385 |
121 | striatum development (GO:0021756) | 2.88772603 |
122 | regulation of synapse maturation (GO:0090128) | 2.88582494 |
123 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.87652454 |
124 | cell migration in hindbrain (GO:0021535) | 2.87362128 |
125 | regulation of synaptic transmission (GO:0050804) | 2.86392483 |
126 | learning (GO:0007612) | 2.86358317 |
127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.84102764 |
128 | behavioral fear response (GO:0001662) | 2.84032807 |
129 | behavioral defense response (GO:0002209) | 2.84032807 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.98938891 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10731853 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16937653 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10243910 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97039159 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.83818479 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69746821 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65865785 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57148851 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57148851 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56358983 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47405878 |
13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45799883 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44071858 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41409903 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38543053 |
17 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24419123 |
18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19942536 |
19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16946542 |
20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12365709 |
21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.11109959 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07615101 |
23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04444417 |
24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04099498 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03186795 |
26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98179604 |
27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97670588 |
28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95313235 |
29 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.94954073 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90199211 |
31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86996033 |
32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82248990 |
33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81818733 |
34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.79115658 |
35 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.76471534 |
36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66593780 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66272319 |
38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61744470 |
39 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60236414 |
40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.57364275 |
41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52539785 |
42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51261989 |
43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47663172 |
44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45737698 |
45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45315547 |
46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44121938 |
47 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43374610 |
48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41484483 |
49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39861074 |
50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39566953 |
51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38352435 |
52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37143951 |
53 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34880671 |
54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34514319 |
55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34498937 |
56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34488435 |
57 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.33190621 |
58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32369841 |
59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31468406 |
60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30453690 |
61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28980597 |
62 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.28264489 |
63 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27916737 |
64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.21997791 |
65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20857187 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19951817 |
67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19085128 |
68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17017771 |
69 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16180564 |
70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14825679 |
71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14622987 |
72 | * JUN_21703547_ChIP-Seq_K562_Human | 1.13947522 |
73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13399481 |
74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12899703 |
75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11827377 |
76 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10997091 |
77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08733174 |
78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08049597 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07936511 |
80 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.07923280 |
81 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07842299 |
82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07703240 |
83 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06765192 |
84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06718385 |
85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06640123 |
86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03217304 |
87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02824371 |
88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01575014 |
89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01263331 |
90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01263331 |
91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01140227 |
92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99373558 |
93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96924077 |
94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96803534 |
95 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95891556 |
96 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95618864 |
97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94686811 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94626532 |
99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93317823 |
100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93097654 |
101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92622969 |
102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92606347 |
103 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.91722262 |
104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91483018 |
105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90229851 |
106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89858161 |
107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89536285 |
108 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89314745 |
109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86686007 |
110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86437285 |
111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86408191 |
112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85814928 |
113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85258273 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.13467871 |
2 | MP0003880_abnormal_central_pattern | 5.05002829 |
3 | MP0001968_abnormal_touch/_nociception | 4.30693935 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.79619210 |
5 | MP0002736_abnormal_nociception_after | 3.76451982 |
6 | MP0002735_abnormal_chemical_nociception | 3.62037590 |
7 | MP0004270_analgesia | 3.57330380 |
8 | MP0009046_muscle_twitch | 3.28274996 |
9 | MP0009745_abnormal_behavioral_response | 3.28199922 |
10 | MP0002064_seizures | 3.10606863 |
11 | MP0002734_abnormal_mechanical_nocicepti | 3.09337048 |
12 | MP0002063_abnormal_learning/memory/cond | 2.99461306 |
13 | MP0002272_abnormal_nervous_system | 2.84563391 |
14 | MP0002733_abnormal_thermal_nociception | 2.73535141 |
15 | MP0002572_abnormal_emotion/affect_behav | 2.71302619 |
16 | MP0006276_abnormal_autonomic_nervous | 2.68012631 |
17 | MP0001970_abnormal_pain_threshold | 2.51923365 |
18 | MP0005423_abnormal_somatic_nervous | 2.50165189 |
19 | MP0001501_abnormal_sleep_pattern | 2.39847541 |
20 | MP0002067_abnormal_sensory_capabilities | 2.32754228 |
21 | MP0001440_abnormal_grooming_behavior | 2.25480777 |
22 | MP0001486_abnormal_startle_reflex | 2.14271792 |
23 | MP0001984_abnormal_olfaction | 2.11590547 |
24 | MP0002822_catalepsy | 2.11070580 |
25 | MP0002184_abnormal_innervation | 2.04325077 |
26 | MP0001905_abnormal_dopamine_level | 1.79189567 |
27 | MP0005386_behavior/neurological_phenoty | 1.72348446 |
28 | MP0004924_abnormal_behavior | 1.72348446 |
29 | MP0001529_abnormal_vocalization | 1.71134459 |
30 | MP0008569_lethality_at_weaning | 1.70777823 |
31 | MP0001986_abnormal_taste_sensitivity | 1.68890484 |
32 | MP0004858_abnormal_nervous_system | 1.68845662 |
33 | MP0002557_abnormal_social/conspecific_i | 1.65969381 |
34 | MP0003329_amyloid_beta_deposits | 1.62054964 |
35 | MP0000778_abnormal_nervous_system | 1.56487840 |
36 | MP0003122_maternal_imprinting | 1.55278264 |
37 | MP0004142_abnormal_muscle_tone | 1.53763729 |
38 | MP0004811_abnormal_neuron_physiology | 1.53472324 |
39 | MP0002837_dystrophic_cardiac_calcinosis | 1.53037826 |
40 | MP0001188_hyperpigmentation | 1.51809382 |
41 | MP0005646_abnormal_pituitary_gland | 1.50239829 |
42 | MP0000955_abnormal_spinal_cord | 1.42584189 |
43 | MP0002909_abnormal_adrenal_gland | 1.36436302 |
44 | MP0002066_abnormal_motor_capabilities/c | 1.35310860 |
45 | MP0002882_abnormal_neuron_morphology | 1.32431676 |
46 | MP0003879_abnormal_hair_cell | 1.30356288 |
47 | MP0005645_abnormal_hypothalamus_physiol | 1.28942238 |
48 | MP0008877_abnormal_DNA_methylation | 1.26744297 |
49 | MP0003633_abnormal_nervous_system | 1.20539024 |
50 | MP0010386_abnormal_urinary_bladder | 1.18151969 |
51 | MP0009780_abnormal_chondrocyte_physiolo | 1.15254767 |
52 | MP0001502_abnormal_circadian_rhythm | 1.14395534 |
53 | MP0002876_abnormal_thyroid_physiology | 1.14332945 |
54 | MP0008872_abnormal_physiological_respon | 1.13721223 |
55 | MP0003787_abnormal_imprinting | 1.11287236 |
56 | MP0004145_abnormal_muscle_electrophysio | 1.06481371 |
57 | MP0003631_nervous_system_phenotype | 1.06427267 |
58 | MP0001485_abnormal_pinna_reflex | 1.06205780 |
59 | MP0002229_neurodegeneration | 0.99029389 |
60 | MP0004742_abnormal_vestibular_system | 0.96717130 |
61 | MP0000751_myopathy | 0.96519834 |
62 | MP0003123_paternal_imprinting | 0.96152837 |
63 | MP0005551_abnormal_eye_electrophysiolog | 0.94858393 |
64 | MP0008874_decreased_physiological_sensi | 0.93105118 |
65 | MP0004147_increased_porphyrin_level | 0.92478016 |
66 | MP0002152_abnormal_brain_morphology | 0.90339563 |
67 | MP0005535_abnormal_body_temperature | 0.85348234 |
68 | MP0002069_abnormal_eating/drinking_beha | 0.84845145 |
69 | MP0003121_genomic_imprinting | 0.83471660 |
70 | MP0005499_abnormal_olfactory_system | 0.83457993 |
71 | MP0005394_taste/olfaction_phenotype | 0.83457993 |
72 | MP0005187_abnormal_penis_morphology | 0.83187325 |
73 | MP0000013_abnormal_adipose_tissue | 0.82272155 |
74 | MP0001963_abnormal_hearing_physiology | 0.81519073 |
75 | MP0004085_abnormal_heartbeat | 0.80575756 |
76 | MP0002752_abnormal_somatic_nervous | 0.79597902 |
77 | MP0002751_abnormal_autonomic_nervous | 0.77691718 |
78 | MP0004484_altered_response_of | 0.77488006 |
79 | MP0004215_abnormal_myocardial_fiber | 0.76377903 |
80 | MP0003632_abnormal_nervous_system | 0.75269735 |
81 | MP0004043_abnormal_pH_regulation | 0.74955325 |
82 | MP0001664_abnormal_digestion | 0.74089205 |
83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73373393 |
84 | MP0000604_amyloidosis | 0.73347817 |
85 | MP0005409_darkened_coat_color | 0.72247084 |
86 | MP0004885_abnormal_endolymph | 0.72101123 |
87 | MP0003634_abnormal_glial_cell | 0.71781115 |
88 | MP0005623_abnormal_meninges_morphology | 0.66985622 |
89 | MP0002090_abnormal_vision | 0.64392887 |
90 | MP0000566_synostosis | 0.62964436 |
91 | MP0002638_abnormal_pupillary_reflex | 0.62840653 |
92 | MP0000631_abnormal_neuroendocrine_gland | 0.58618089 |
93 | MP0001177_atelectasis | 0.57107152 |
94 | MP0001943_abnormal_respiration | 0.56544824 |
95 | MP0006072_abnormal_retinal_apoptosis | 0.55544405 |
96 | MP0001299_abnormal_eye_distance/ | 0.55328109 |
97 | MP0005171_absent_coat_pigmentation | 0.55068129 |
98 | MP0010768_mortality/aging | 0.54435763 |
99 | MP0003861_abnormal_nervous_system | 0.54222830 |
100 | MP0000920_abnormal_myelination | 0.54156811 |
101 | MP0000026_abnormal_inner_ear | 0.53391297 |
102 | MP0003183_abnormal_peptide_metabolism | 0.52782988 |
103 | MP0004133_heterotaxia | 0.52477378 |
104 | MP0002102_abnormal_ear_morphology | 0.50960629 |
105 | MP0003137_abnormal_impulse_conducting | 0.49808077 |
106 | MP0006035_abnormal_mitochondrial_morpho | 0.49419461 |
107 | MP0003956_abnormal_body_size | 0.47153538 |
108 | MP0004036_abnormal_muscle_relaxation | 0.46465126 |
109 | MP0000538_abnormal_urinary_bladder | 0.44039917 |
110 | MP0010770_preweaning_lethality | 0.43943112 |
111 | MP0002082_postnatal_lethality | 0.43943112 |
112 | MP0005410_abnormal_fertilization | 0.43382515 |
113 | MP0000569_abnormal_digit_pigmentation | 0.43002030 |
114 | MP0010769_abnormal_survival | 0.42482839 |
115 | MP0005379_endocrine/exocrine_gland_phen | 0.42270026 |
116 | MP0003690_abnormal_glial_cell | 0.41289013 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.91882527 |
2 | Myokymia (HP:0002411) | 6.05561026 |
3 | Atonic seizures (HP:0010819) | 5.81863713 |
4 | Focal seizures (HP:0007359) | 5.81177554 |
5 | Febrile seizures (HP:0002373) | 5.23289134 |
6 | Visual hallucinations (HP:0002367) | 5.15132902 |
7 | Epileptic encephalopathy (HP:0200134) | 5.03328912 |
8 | Absence seizures (HP:0002121) | 4.59367036 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.55390444 |
10 | Dialeptic seizures (HP:0011146) | 4.25981682 |
11 | Action tremor (HP:0002345) | 3.93234179 |
12 | Intention tremor (HP:0002080) | 3.84593733 |
13 | Hyperventilation (HP:0002883) | 3.82133188 |
14 | Generalized tonic-clonic seizures (HP:0002069) | 3.81931715 |
15 | Limb dystonia (HP:0002451) | 3.68674057 |
16 | Pheochromocytoma (HP:0002666) | 3.62216773 |
17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.38969936 |
18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.38969936 |
19 | Broad-based gait (HP:0002136) | 3.36451589 |
20 | Neuroendocrine neoplasm (HP:0100634) | 3.36063426 |
21 | Gaze-evoked nystagmus (HP:0000640) | 3.21442257 |
22 | Truncal ataxia (HP:0002078) | 3.16419327 |
23 | Amblyopia (HP:0000646) | 3.10503792 |
24 | Insidious onset (HP:0003587) | 2.95747382 |
25 | Termporal pattern (HP:0011008) | 2.95747382 |
26 | Poor eye contact (HP:0000817) | 2.94301524 |
27 | Failure to thrive in infancy (HP:0001531) | 2.85643703 |
28 | Abnormal eating behavior (HP:0100738) | 2.82032154 |
29 | Progressive inability to walk (HP:0002505) | 2.81637274 |
30 | Dysdiadochokinesis (HP:0002075) | 2.79763688 |
31 | Impaired social interactions (HP:0000735) | 2.79486293 |
32 | Abnormal social behavior (HP:0012433) | 2.79486293 |
33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75980685 |
34 | Abnormality of saccadic eye movements (HP:0000570) | 2.73297837 |
35 | Anxiety (HP:0000739) | 2.72883537 |
36 | Supranuclear gaze palsy (HP:0000605) | 2.71937181 |
37 | Dysmetria (HP:0001310) | 2.68956751 |
38 | Depression (HP:0000716) | 2.63373878 |
39 | Hypothermia (HP:0002045) | 2.63347979 |
40 | Hemiplegia (HP:0002301) | 2.59047420 |
41 | Ankle clonus (HP:0011448) | 2.58599012 |
42 | Inability to walk (HP:0002540) | 2.58297672 |
43 | Abnormal hair whorl (HP:0010721) | 2.54643384 |
44 | Epileptiform EEG discharges (HP:0011182) | 2.50060479 |
45 | Scanning speech (HP:0002168) | 2.48693476 |
46 | Gait imbalance (HP:0002141) | 2.46466281 |
47 | Diplopia (HP:0000651) | 2.45089996 |
48 | Abnormality of binocular vision (HP:0011514) | 2.45089996 |
49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.39969496 |
50 | Acute necrotizing encephalopathy (HP:0006965) | 2.38900586 |
51 | Polyphagia (HP:0002591) | 2.37081613 |
52 | Drooling (HP:0002307) | 2.36135205 |
53 | Excessive salivation (HP:0003781) | 2.36135205 |
54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34853565 |
55 | Neurofibrillary tangles (HP:0002185) | 2.34564868 |
56 | Abnormality of pain sensation (HP:0010832) | 2.32282531 |
57 | Impaired pain sensation (HP:0007328) | 2.32282531 |
58 | Progressive macrocephaly (HP:0004481) | 2.31352767 |
59 | Lower limb muscle weakness (HP:0007340) | 2.31313368 |
60 | Hypoventilation (HP:0002791) | 2.26442567 |
61 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24085480 |
62 | Ulnar claw (HP:0001178) | 2.23777605 |
63 | Congenital primary aphakia (HP:0007707) | 2.23459896 |
64 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.22018954 |
65 | Fetal akinesia sequence (HP:0001989) | 2.20753689 |
66 | Medial flaring of the eyebrow (HP:0010747) | 2.20687040 |
67 | Impaired smooth pursuit (HP:0007772) | 2.20494064 |
68 | Abnormality of the corticospinal tract (HP:0002492) | 2.16611992 |
69 | Hypsarrhythmia (HP:0002521) | 2.16196578 |
70 | Hemiparesis (HP:0001269) | 2.15845396 |
71 | Cerebral inclusion bodies (HP:0100314) | 2.13884633 |
72 | Absent speech (HP:0001344) | 2.13680003 |
73 | Postural tremor (HP:0002174) | 2.13422955 |
74 | Mutism (HP:0002300) | 2.12110663 |
75 | Bradykinesia (HP:0002067) | 2.10870215 |
76 | Genital tract atresia (HP:0001827) | 2.10083358 |
77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08793137 |
78 | Spastic gait (HP:0002064) | 2.08783512 |
79 | Urinary urgency (HP:0000012) | 2.08477082 |
80 | Status epilepticus (HP:0002133) | 2.07980002 |
81 | Dysautonomia (HP:0002459) | 2.07281249 |
82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06347411 |
83 | Gait ataxia (HP:0002066) | 2.05246404 |
84 | Limb ataxia (HP:0002070) | 2.04694178 |
85 | Abnormality of the lower motor neuron (HP:0002366) | 2.04283179 |
86 | Vaginal atresia (HP:0000148) | 2.04170505 |
87 | Agitation (HP:0000713) | 2.02564380 |
88 | Cerebral hypomyelination (HP:0006808) | 2.02479652 |
89 | Hyperthyroidism (HP:0000836) | 2.02421597 |
90 | Psychosis (HP:0000709) | 2.02042604 |
91 | Delusions (HP:0000746) | 2.02009190 |
92 | Specific learning disability (HP:0001328) | 2.01429663 |
93 | Esotropia (HP:0000565) | 1.99301887 |
94 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.98812650 |
95 | Retinal dysplasia (HP:0007973) | 1.96719498 |
96 | Myotonia (HP:0002486) | 1.94437091 |
97 | Akinesia (HP:0002304) | 1.94233347 |
98 | Blue irides (HP:0000635) | 1.92259315 |
99 | Exotropia (HP:0000577) | 1.91593893 |
100 | Mitochondrial inheritance (HP:0001427) | 1.91030954 |
101 | Torticollis (HP:0000473) | 1.88851683 |
102 | Horizontal nystagmus (HP:0000666) | 1.88807644 |
103 | Dysmetric saccades (HP:0000641) | 1.88458887 |
104 | Postural instability (HP:0002172) | 1.88394125 |
105 | Focal dystonia (HP:0004373) | 1.87987373 |
106 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.87458860 |
107 | Neuronal loss in central nervous system (HP:0002529) | 1.86161960 |
108 | Incomplete penetrance (HP:0003829) | 1.85150945 |
109 | Impaired vibratory sensation (HP:0002495) | 1.82250455 |
110 | Protruding tongue (HP:0010808) | 1.81345341 |
111 | Genetic anticipation (HP:0003743) | 1.80565311 |
112 | Generalized myoclonic seizures (HP:0002123) | 1.80531834 |
113 | Craniofacial dystonia (HP:0012179) | 1.80139261 |
114 | Papilledema (HP:0001085) | 1.78595841 |
115 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78521854 |
116 | Aplasia involving bones of the extremities (HP:0009825) | 1.78521854 |
117 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.78521854 |
118 | Tetraplegia (HP:0002445) | 1.76384610 |
119 | Sleep apnea (HP:0010535) | 1.75848211 |
120 | Spastic tetraplegia (HP:0002510) | 1.73316938 |
121 | Rigidity (HP:0002063) | 1.71819496 |
122 | Dysarthria (HP:0001260) | 1.71752219 |
123 | Syncope (HP:0001279) | 1.69152667 |
124 | Slow progression (HP:0003677) | 1.68326152 |
125 | Peripheral hypomyelination (HP:0007182) | 1.63382506 |
126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.61026969 |
127 | Choreoathetosis (HP:0001266) | 1.60497845 |
128 | Prolonged QT interval (HP:0001657) | 1.60088130 |
129 | Heterochromia iridis (HP:0001100) | 1.59119870 |
130 | Annular pancreas (HP:0001734) | 1.58763900 |
131 | Apathy (HP:0000741) | 1.58453477 |
132 | CNS hypomyelination (HP:0003429) | 1.56373109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.27805093 |
2 | CASK | 3.48169562 |
3 | MAP3K9 | 3.40128918 |
4 | MAP3K12 | 3.30924353 |
5 | MAP3K4 | 3.30042911 |
6 | EPHA4 | 3.12575951 |
7 | MAP2K7 | 2.98676180 |
8 | MINK1 | 2.72529320 |
9 | RIPK4 | 2.71310170 |
10 | GRK5 | 2.48334457 |
11 | DAPK2 | 2.27961393 |
12 | MAP2K4 | 2.27339666 |
13 | ARAF | 2.06058722 |
14 | NTRK1 | 2.05149790 |
15 | KSR2 | 1.98456436 |
16 | PLK2 | 1.87107504 |
17 | PNCK | 1.82590825 |
18 | MARK1 | 1.78284564 |
19 | MAP4K2 | 1.73748150 |
20 | DAPK1 | 1.60643241 |
21 | PAK6 | 1.55687326 |
22 | MAP3K11 | 1.50429492 |
23 | CAMKK2 | 1.47243340 |
24 | NTRK2 | 1.46567675 |
25 | KSR1 | 1.32424614 |
26 | CDK5 | 1.30730489 |
27 | CDK19 | 1.30468380 |
28 | PRPF4B | 1.26950633 |
29 | MAPK13 | 1.25653576 |
30 | PRKCG | 1.24183388 |
31 | PTK2B | 1.16960690 |
32 | CAMK2A | 1.16168465 |
33 | CAMKK1 | 1.15617360 |
34 | TNIK | 1.14708417 |
35 | SIK3 | 1.14702092 |
36 | FES | 1.11555014 |
37 | MAP3K2 | 1.09399556 |
38 | CSNK1G3 | 1.08577458 |
39 | SGK223 | 1.08397167 |
40 | SGK494 | 1.08397167 |
41 | CSNK1A1L | 1.08144290 |
42 | CAMK2B | 1.05623743 |
43 | SGK2 | 1.05027211 |
44 | NME1 | 1.00133800 |
45 | MAPKAPK5 | 0.96506142 |
46 | BMPR2 | 0.95965636 |
47 | UHMK1 | 0.91177489 |
48 | CDK14 | 0.91070728 |
49 | SIK2 | 0.90405621 |
50 | MAP3K13 | 0.89994333 |
51 | FER | 0.89151082 |
52 | RET | 0.88850261 |
53 | OXSR1 | 0.88701212 |
54 | CDK18 | 0.87194261 |
55 | CCNB1 | 0.87053268 |
56 | AKT3 | 0.85968220 |
57 | PRKD3 | 0.84419340 |
58 | CSNK1G1 | 0.82669347 |
59 | ADRBK2 | 0.81941859 |
60 | GRK7 | 0.81486974 |
61 | CDK15 | 0.80529020 |
62 | STK38 | 0.78021349 |
63 | CAMK2D | 0.77787224 |
64 | WNK3 | 0.77199216 |
65 | LATS2 | 0.76591947 |
66 | PRKCE | 0.73510914 |
67 | BRAF | 0.70601023 |
68 | LIMK1 | 0.69438620 |
69 | PRKG1 | 0.69411457 |
70 | CDK11A | 0.69103719 |
71 | SGK3 | 0.67544749 |
72 | TNK2 | 0.67227972 |
73 | TYRO3 | 0.66675957 |
74 | CSNK1G2 | 0.66557827 |
75 | LMTK2 | 0.66433266 |
76 | PHKG2 | 0.65743683 |
77 | PHKG1 | 0.65743683 |
78 | RAF1 | 0.65646046 |
79 | CAMK2G | 0.65272473 |
80 | MAP2K1 | 0.62397573 |
81 | MAP3K5 | 0.62347650 |
82 | ADRBK1 | 0.61713748 |
83 | CAMK1 | 0.61197222 |
84 | PINK1 | 0.60908507 |
85 | MAP3K1 | 0.60086424 |
86 | CAMK4 | 0.59801875 |
87 | DYRK1A | 0.58222339 |
88 | BCR | 0.57375424 |
89 | PAK3 | 0.57149774 |
90 | FGR | 0.56980497 |
91 | WNK1 | 0.55384833 |
92 | PRKCH | 0.53758405 |
93 | MAPK10 | 0.53719055 |
94 | FYN | 0.52719930 |
95 | TSSK6 | 0.52479013 |
96 | MARK2 | 0.51138952 |
97 | SGK1 | 0.50736539 |
98 | PRKCA | 0.49244516 |
99 | STK11 | 0.48938794 |
100 | MAPK12 | 0.48810151 |
101 | PKN1 | 0.45892055 |
102 | FRK | 0.44841794 |
103 | NEK6 | 0.44652035 |
104 | STK39 | 0.44405415 |
105 | PDK1 | 0.42740812 |
106 | RPS6KA2 | 0.41871118 |
107 | PDK4 | 0.41377661 |
108 | PDK3 | 0.41377661 |
109 | PDPK1 | 0.40929455 |
110 | PRKACA | 0.40701488 |
111 | CSNK1E | 0.40636858 |
112 | GRK6 | 0.40197649 |
113 | CSNK1D | 0.39422959 |
114 | MAP3K6 | 0.38299809 |
115 | PRKCZ | 0.38058827 |
116 | PRKCB | 0.36987943 |
117 | CSNK1A1 | 0.36935208 |
118 | MUSK | 0.36794451 |
119 | RPS6KA3 | 0.35525746 |
120 | WNK4 | 0.35189277 |
121 | ROCK2 | 0.34851967 |
122 | ALK | 0.34285375 |
123 | DAPK3 | 0.32653460 |
124 | PRKDC | 0.32230371 |
125 | TESK1 | 0.27658358 |
126 | DYRK2 | 0.24920062 |
127 | SRC | 0.24904713 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.01958969 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.75088447 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84478514 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64759373 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60965095 |
6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.58006183 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57499331 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51895482 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45649384 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43019610 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.41135704 |
12 | Taste transduction_Homo sapiens_hsa04742 | 2.24422157 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23571791 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21757970 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 2.07001805 |
16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99738140 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.97564527 |
18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94203769 |
19 | Long-term depression_Homo sapiens_hsa04730 | 1.91490878 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88744462 |
21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73515214 |
22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72344006 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.65642942 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61850679 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56249240 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55285819 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55071259 |
28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52557749 |
29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49124681 |
30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47508521 |
31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.47275038 |
32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44194238 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.43189201 |
34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42984322 |
35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42676035 |
36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32990740 |
37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32679542 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31971375 |
39 | Gap junction_Homo sapiens_hsa04540 | 1.21941810 |
40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18528110 |
41 | Phototransduction_Homo sapiens_hsa04744 | 1.11718583 |
42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07657750 |
43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06253703 |
44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01201219 |
45 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99468677 |
46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92778903 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90024309 |
48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87614007 |
49 | Melanogenesis_Homo sapiens_hsa04916 | 0.86279578 |
50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85406321 |
51 | Glioma_Homo sapiens_hsa05214 | 0.83796123 |
52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83167123 |
53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82556031 |
54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79433225 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78936897 |
56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78847225 |
57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76744530 |
58 | Axon guidance_Homo sapiens_hsa04360 | 0.75094223 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71429867 |
60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69374308 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69173471 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62509020 |
63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61376230 |
64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55327743 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54876183 |
66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54770800 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52251121 |
68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51178492 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50104055 |
70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49250178 |
71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49004409 |
72 | Alcoholism_Homo sapiens_hsa05034 | 0.48895916 |
73 | Phagosome_Homo sapiens_hsa04145 | 0.47196306 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45885221 |
75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43792827 |
76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43773137 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43585596 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42972494 |
79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42319459 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41738201 |
81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41314276 |
82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41231813 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38179450 |
84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37503606 |
85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35132942 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33066963 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.32238880 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31723180 |
89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30253800 |
90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29897027 |
91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29250047 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26048371 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.25766158 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.24918011 |
95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24858034 |
96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24436986 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24341458 |
98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24150946 |
99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23730207 |
100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23214932 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.22684297 |
102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22660956 |
103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21306957 |
104 | Melanoma_Homo sapiens_hsa05218 | 0.20942750 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20340061 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20306817 |
107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.18853519 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18275778 |
109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16114833 |
110 | Tight junction_Homo sapiens_hsa04530 | 0.15757629 |
111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.10457712 |
112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.09754641 |
113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.08979379 |